doi: 10.1001/jama.2022.0078 39 Chang-ChenKJMullurRBernal-MizrachiE
Para los pacientes, esto significa que el tratamiento del hgado graso ya no se limita a recomendaciones generales, sino que comienza a apoyarse en opciones teraputicas con bases cientficas slidas
NutraKey creates clean, science-driven supplements that fuel performance, recovery, and overall health
Key Findings (20-year risks in early-onset AF vs matched controls): Stroke: 6.9% | 2x higher risk Heart Failure: 6.5% | 45x higher risk Death: 7.1% | 1.4x higher risk Take-home message: Even in the absence of traditional comorbidities, early-onset AF is a marker of future cardiovascular complicationsespecially cardiomyopathy and HF
A follow-up analysis found that liraglutide slowed down stomach emptying in 57% of obesity patients, but tachyphylaxis helped 19 out of 39 affected patients return to normal within 16 weeks [28]
But researchers with study designs that are not compatible with injections may prefer the nasal spray format